RxDoctor Payments Data

Robert Adams, MD

Child & Adolescent Psychiatry · Wilmington, NCNPI 1275693517

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.3% of the total across 57 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Johnson & Johnson at 30.6% of the total. Reporting peaked in 2024 at $669 and has fallen 86.0% since, to $93 in 2025.

$1,647in general payments, 2019–2025

Across 57 payments — averaging $28.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$504
  • Alkermes, Inc.$194
  • Axsome Therapeutics, Inc.$175
  • Neurocrine Biosciences, Inc.$156
  • Corium, LLC$127
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$119
  • plus $371 from 9 others

What the payments were for

  • Food & beverage$1,62098%
  • Education$272%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,647 in reported general payments places this provider in the 85th percentile of 91 child & adolescent psychiatry providers in North Carolina.

See all child & adolescent psychiatry providers in North Carolina

Medicare billing

Part B allowed, 2024
$29,866
Medicare patients
84
Services billed
313

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate11$49,362
AzstarysSerdexmethylphen/Dexmethylphen13$6,179
Quetiapine Fumarate ErQuetiapine Fumarate56$5,767
Divalproex Sodium ErDivalproex Sodium64$5,138
Chlorpromazine Hcl14$2,523
Atomoxetine Hcl24$2,195
Clozapine12$1,941
Ziprasidone Hcl13$1,637
Duloxetine Hcl28$904
Guanfacine Hcl ErGuanfacine Hcl19$859
Clonazepam86$817
Trazodone Hcl71$762
Olanzapine47$613
AmantadineAmantadine Hcl12$567
Quetiapine Fumarate41$565

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$504$49,36211 claims
Corium, LLCAzstarys$127$6,17913 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 91 child & adolescent psychiatry providers in North Carolina.

Other child & adolescent psychiatry in Wilmington

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →